EBMT
Eagle Bancorp Montana, Inc.
EBMT offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MS
Morgan Stanley
MS has a slight edge over EBMT overall, supported by stronger fundamentals and stronger modeled upside.
EBMT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
EBMT's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like EBMT.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
EBMT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.8x | $15.45 | -25% |
| Forward | 9x | $20.61 | — |
| Fair | 10x | $20.77 | +0.8% |
| Current | 10x | $20.61 | — |
| Expensive | 13x | $24.90 | +21% |
Historical ranges are pointers, not guarantees.
EBMT has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
EBMT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for EBMT, with profitability improving. However, they disagree widely on these estimates.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
EBMT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +16% |
| Q3 2026 | $1.98 | +15% |
| Q2 2026 | $2.06 | +29% |
| Q1 2026 | $2.00 | +42% |
| Q4 2025 | $1.90 | +53% |
| Q3 2025 | $1.72 | +61% |
| Q2 2025 | $1.60 | +50% |
| Q1 2025 | $1.41 | +27% |
| Q4 2024 | $1.24 | -3.9% |
EBMT's earnings per share have fallen from their peak: $1.98 over the past year, against $3.32 in early 2021.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over EBMT on earnings, with more consistent year-over-year improvement.
EBMT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $25.1M | +7.2% |
| Q2 2026 | $24.2M | +5.2% |
| Q1 2026 | $23.6M | +13% |
| Q4 2025 | $24.3M | +14% |
| Q3 2025 | $23.4M | +13% |
| Q2 2025 | $23M | +15% |
| Q1 2025 | $20.9M | +9.1% |
| Q4 2024 | $21.4M | +1.7% |
EBMT's revenue has grown year over year for eight quarters in a row: $25M last quarter, up 7.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | -5.8 points |
| Q2 2026 | 20% | +2.6 points |
| Q1 2026 | 22% | +3.1 points |
| Q4 2025 | 25% | +7.7 points |
| Q3 2025 | 21% | +5.6 points |
| Q2 2025 | 17% | +6.4 points |
| Q1 2025 | 19% | +6.7 points |
| Q4 2024 | 17% | +8.5 points |
EBMT's operating margin was 15% last quarter, down 5.8 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over EBMT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over EBMT on profitability, with a higher operating margin.
EBMT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.5M | +34% |
| Q2 2026 | -$2.8M | -301% |
| Q1 2026 | -$5.2M | -2079% |
| Q4 2025 | $19.6M | +60% |
| Q3 2025 | $7.1M | +$7.8M |
| Q2 2025 | $1.4M | +121% |
| Q1 2025 | $262K | -89% |
| Q4 2024 | $12.2M | +27% |
EBMT has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
EBMT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +11.5K shares |
| 1 year | +0.6% | +45.4K shares |
| 3 years | +1.1% | +82K shares |
| 5 years | +20% | +1.3M shares |
| Available history | +22% | +1.4M shares |
EBMT has 8M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $410,000 |
| Q3 2025 | — |
| Q2 2025 | $408,000 |
| Q1 2025 | $755,000 |
| Q4 2024 | $419,000 |
EBMT spent $410,000 buying back its own shares over the past year, down 74% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over EBMT on shareholder dilution, with a more favorable share count trend.
EBMT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.5x | Healthy |
EBMT has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
EBMT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.8 | Neutral |
| Stochastic | 18.6 | Oversold |
EBMT's weekly RSI is 39 (neutral) and its Stochastic is 19 (oversold).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
EBMT PE vs Financial Services Sector
| Metric | EBMT | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 20% below |
| PE % | 48 | 63 | 15 pts below |
EBMT has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
EBMT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.0 | 1.9% below |
| 20 week MA | $22.3 | 7.4% below |
| 50 week MA | $21.8 | 5.4% below |
| 100 week MA | $19.2 | 7.5% above |
| 200 week MA | $16.6 | 24% above |
EBMT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 24% above its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over EBMT on trend strength, trading above more of its moving averages.
EBMT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.1 | $21.9 | +3.8% |
| 2021 | $21.9 | $22.9 | +4.7% |
| 2022 | $22.9 | $16.2 | -29% |
| 2023 | $16.2 | $15.8 | -2.4% |
| 2024 | $15.8 | $15.3 | -3.4% |
| 2025 | $15.3 | $19.8 | +30% |
| 2026 YTD | $19.8 | $20.6 | +4.2% |
EBMT has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.